Sagimet Biosciences Inc-a (SGMT) — Institutional Holders Breakdown (Q2 2026)

SGMT ranks #4101 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

125 institutions disclose a position in SGMT, but none treat it as a major bet — even Great Point Partners LLC, its most concentrated holder, allocates just 3.0% of its own portfolio to it.

FNY Investment Advisers, LLC has added to its SGMT position for two straight quarters, increasing it by $298.0K to reach $1.1M today.

SGMT is up 8.3% today, and institutions have been net buyers of $310.1M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

SGMT reported a net loss of $51.0M in its latest fiscal year.

• Not yet profitable — net loss of $51.0M in the latest fiscal year
• Net income declined year over year, from -$45.6M to -$51.0M
• Operating cash flow was negative, using $45.7M in cash
• Current ratio of 22.82x — enough short-term assets to cover short-term liabilities
• Liabilities run x equity — a highly leveraged balance sheet worth noting